Endovia Health Sciences (EDVA) Change in Account Payables (2012 - 2020)
Analysis
Endovia Health Sciences (EDVA) Change in Account Payables (2012 - 2020) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 141.50 Bn | 133.65 Bn | 2.84 Bn | -66.70 Mn |
| 2 | Regeneron Pharmaceuticals | 86.53 Bn | 78.54 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 65.05 Bn | 59.86 Bn | 1.37 Bn | - |
| 4 | Moderna | 57.11 Bn | 51.98 Bn | 52.00 Mn | -8.00 Mn |
| 5 | Revolution Medicines | 44.71 Bn | 44.71 Bn | - | 5.03 Mn |
| 6 | BeOne Medicines | 40.40 Bn | 35.31 Bn | 1.53 Bn | 37.53 Mn |
| 7 | Alnylam Pharmaceuticals | 35.36 Bn | 32.05 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.16 Bn | 27.32 Bn | - | - |
| 9 | Insmed | 27.40 Bn | 26.24 Bn | 358.27 Mn | - |
| 10 | Endovia Health Sciences | 801,166.21 | 558,464.21 | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2020 | -90,000.00 |
| Jun 30, 2020 | 45,000.00 |
| Mar 31, 2020 | 6,000.00 |
| Dec 31, 2019 | 39,000.00 |
| Jun 30, 2019 | -56,746.00 |
| Mar 31, 2019 | 35,684.00 |
| Dec 31, 2018 | 65,771.00 |
| Sep 30, 2018 | 23,329.00 |
| Jun 30, 2018 | -88,284.00 |
| Mar 31, 2018 | 104,008.00 |
| Dec 31, 2017 | -5,560.00 |
| Sep 30, 2017 | 31,438.00 |
| Jun 30, 2017 | -806.00 |
| Mar 31, 2017 | -7,933.00 |
| Dec 31, 2016 | 60,432.00 |
| Sep 30, 2016 | 20,820.00 |
| Jun 30, 2016 | -14,810.00 |
| Mar 31, 2016 | 7,416.00 |
| Dec 31, 2015 | 39,098.00 |
| Sep 30, 2015 | -12,360.00 |